STB
CVS icon

S&T Bank’s CVS Health CVS Stock Holding History

S&T Bank’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
19,471
-7,708
-28% -$688K 0.6% 35
2026
Q1 		$1.95M Sell
27,179
-19,380
-42% -$1.49M 0.73% 36
2025
Q4 		$3.69M Sell
46,559
-11,402
-20% -$899K 1.17% 31
2025
Q3 		$4.37M Sell
57,961
-14,586
-20% -$1,000K 1.23% 32
2025
Q2 		$5M Sell
72,547
-4,312
-6% -$283K 1.52% 30
2025
Q1 		$5.21M Sell
76,859
-1,101
-1% -$65.9K 1.7% 20
2024
Q4 		$3.5M Sell
77,960
-9,790
-11% -$549K 1.12% 36
2024
Q3 		$5.52M Sell
87,750
-17,505
-17% -$1.02M 1.45% 30
2024
Q2 		$6.22M Sell
105,255
-21,554
-17% -$1.35M 1.58% 27
2024
Q1 		$10.1M Sell
126,809
-16,038
-11% -$1.23M 1.94% 18
2023
Q4 		$11.3M Sell
142,847
-4,261
-3% -$303K 2.08% 13
2023
Q3 		$10.3M Sell
147,108
-139
-0.1% -$9.85K 1.98% 13
2023
Q2 		$10.2M Sell
147,247
-1,896
-1% -$135K 1.83% 22
2023
Q1 		$11.1M Sell
149,143
-2,485
-2% -$208K 2% 14
2022
Q4 		$14.1M Sell
151,628
-1,552
-1% -$150K 2.61% 5
2022
Q3 		$14.6M Sell
153,180
-8,565
-5% -$848K 2.82% 2
2022
Q2 		$15M Sell
161,745
-1,823
-1% -$178K 2.63% 4
2022
Q1 		$16.6M Sell
163,568
-1,773
-1% -$186K 2.5% 6
2021
Q4 		$17.1M Buy
165,341
+311
+0.2% +$28.7K 2.49% 7
2021
Q3 		$14M Buy
165,030
+34,848
+27% +$2.92M 2.17% 10
2021
Q2 		$10.9M Buy
130,182
+4,912
+4% +$402K 1.69% 20
2021
Q1 		$9.42M Buy
125,270
+3,837
+3% +$279K 1.53% 28
2020
Q4 		$8.29M Buy
121,433
+1,335
+1% +$86.8K 1.49% 29
2020
Q3 		$7.01M Sell
120,098
-8,181
-6% -$509K 1.6% 28
2020
Q2 		$8.33M Buy
128,279
+7,225
+6% +$455K 1.9% 15
2020
Q1 		$7.18M Buy
+121,054
New +$8.08M 1.98% 15

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

S&T Bank's CVS Position: Q2 2026 in Review

S&T Bank reduced its CVS Health (CVS) stake by 28% in Q2 2026, selling an estimated $688K and leaving 19,471 shares worth $2.01M. The position accounts for 0.6% of the portfolio, ranked #35.

S&T Bank first reported a position in CVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $17.1M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • S&T Bank held 19,471 shares of CVS Health worth $2.01M as of Q2 2026.
  • S&T Bank sold 7,708 CVS Health shares in Q2 2026, an estimated $688K.
  • CVS Health made up 0.6% of S&T Bank's portfolio in Q2 2026, its #35 holding.
  • S&T Bank first reported a position in CVS Health in Q1 2020 and has held it in 26 quarters since.
  • S&T Bank's CVS Health position peaked at $17.1M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.